Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Chaitanya Sarawate"'
Autor:
Vincent J. Willey, Mark J. Cziraky, Debra A. Wertz, Rhonda L. Bohn, Chaitanya Sarawate, Chun-Lan Chang
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 3:538-545
Background— This study directly compares risk of acute myocardial infarction (AMI), acute heart failure (AHF), or all-cause death among pioglitazone- and rosiglitazone-treated patients in a managed-care population. Methods and Results— Patients
Cardiovascular morbidity, heart rates and use of antimuscarinics in patients with overactive bladder
Autor:
Amit S. Kulkarni, Chaitanya Sarawate, Elizabeth L. Stanley, Karl-Erik Andersson, Kristijan H. Kahler
Publikováno v:
BJU International. 106:268-274
Study Type – Symptom prevalence (retrospective cohort) Level of Evidence 2b OBJECTIVE To determine if cardiovascular (CV) comorbidity and treatment-associated antimuscarinic effects differ between patients with and without overactive bladder (OAB),
Autor:
Hiangkiat Tan, Brian A. Smart, Joseph Singer, Michael Schatz, Michael F. Busk, James V. Lustig, Jeana D. O'Brien, Kurt Elward, Chaitanya Sarawate, Rubin I. Cohen
Publikováno v:
Mayo Clinic Proceedings. 84:675-684
To comprehensively evaluate clinical, economic, and patient-reported outcomes associated with various therapeutic classes of asthma controller medications.This observational study, which used administrative claims data from US commercial health plans
Publikováno v:
Current Medical Research and Opinion. 23:553-563
Current prevention guidelines support efforts to achieve optimal high-density lipoprotein (HDL-C) and triglyceride (TG) values, in addition to low-density lipoprotein (LDL-C) in order to reduce cardiovascular (CV) events. The study objective was to e
Autor:
John Corbelli, Chaitanya Sarawate, Mark J. Cziraky, Scott L. Charland, Vincent J. Willey, Eric J. Stanek
Publikováno v:
Clinical Therapeutics. 29:196-209
Published guidelines suggest the management of high-density lipoprotein cholesterol (HDL-C) and triglyceride (TG) values after the low-density lipoprotein cholesterol (LDL-C) goal is achieved.This study evaluated the attainment of optimal combined li
Autor:
Kathleen K. Brewer, Wenya Yang, Chaitanya Sarawate, H Schumacher, Alan W. Bakst, Pankaj A. Patel
Publikováno v:
JCR: Journal of Clinical Rheumatology. 12:61-65
The desired serum urate level (SUA) for prevention of gout attacks is widely recommended to be in the subsaturating range,6.0 mg/dL.The objectives of this study were to evaluate attainment of this target SUA among gout patients on allopurinol in a na
Publikováno v:
Journal of Thrombosis and Thrombolysis. 21:191-198
Randomized control trials and observational studies show high-quality warfarin therapy leads to safe and effective stroke prophylaxis. In usual community practice, patient, physician and health care system factors are barriers to optimal anticoagulat
Autor:
Chaitanya Sarawate, Roger S. Blumenthal, Noel Bairey Merz, Karol E. Watson, Rosalind P. Fabunmi, Lori Mosca, Eric J. Stanek, Mark J. Cziraky, Vincent J. Willey
Publikováno v:
Circulation. 111:488-493
Background—The American Heart Association (AHA) recently established evidence-based recommendations for cardiovascular disease (CVD) prevention in women, including lipid management. This study evaluated optimal lipid-level attainment and treatment
Cardiovascular morbidity, heart rates and use of antimuscarinics in patients with overactive bladder
Autor:
Karl-Erik, Andersson, Chaitanya, Sarawate, Kristijan H, Kahler, Elizabeth L, Stanley, Amit S, Kulkarni
Publikováno v:
BJU international. 106(2)
To determine if cardiovascular (CV) comorbidity and treatment-associated antimuscarinic effects differ between patients with and without overactive bladder (OAB), and between treated and untreated patients with OAB, as OAB, CV disorders and exposure
Autor:
Alan W. Bakst, Chaitanya Sarawate, Kathleen K. Brewer, Wenya Yang, Pankaj A. Patel, H. Ralph Schumacher, Kenneth G. Saag
Publikováno v:
Mayo Clinic proceedings. 81(7)
OBJECTIVE To determine allopurinol treatment patterns and adherence to published standards of care for patients with gout. PATIENTS AND METHODS This retrospective claims analysis in a managed care database included patients 18 years or older, with co